TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mangalam Drugs & Organics Ltd. ( (IN:MANGALAM) ) just unveiled an announcement.
Mangalam Drugs & Organics Ltd. announced the publication of its unaudited financial results for the quarter and half-year ending September 30, 2025. These results, approved by the Board of Directors, were published in Financial Express and Loksatta newspapers. The company reported a decrease in net profit compared to the previous year, which may impact its financial standing and investor confidence.
More about Mangalam Drugs & Organics Ltd.
Mangalam Drugs & Organics Ltd. operates in the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and intermediates. The company is based in Mumbai, India, and has a manufacturing facility in Vapi, Gujarat.
Average Trading Volume: 4,449
Technical Sentiment Signal: Sell
Current Market Cap: 864.4M INR
See more insights into MANGALAM stock on TipRanks’ Stock Analysis page.